Table 5.
Associations of PDX1 with adverse pregnancy outcomes.
| Items | Model 1 | Model 2 | ||||
|---|---|---|---|---|---|---|
| OR | 95%CI | P | OR | 95%CI | P | |
| Pre-eclampsia | ||||||
| Per 1 pg/mL | 0.967 | 0.928-1.008 | 0.110 | 0.971 | 0.932-1.012 | 0.160 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 0.319 | 0.063-1.613 | 0.167 | 0.320 | 0.055-1.845 | 0.202 |
| Fetal growth restriction | ||||||
| Per 1 pg/mL | 0.994 | 0.968-1.021 | 0.646 | 0.990 | 0.962-1.019 | 0.496 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 1.143 | 0.400-3.262 | 0.803 | 1.020 | 0.348-2.988 | 0.971 |
| Preterm birth | ||||||
| Per 1 pg/mL | 0.974 | 0.948-1.001 | 0.059 | 0.971 | 0.942-1.000 | 0.049 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 0.353 | 0.122-1.026 | 0.056 | 0.326 | 0.104-1.021 | 0.054 |
| Macrosomia | ||||||
| Per 1 pg/mL | 0.951 | 0.921-0.982 | 0.002 | 0.942 | 0.909-0.977 | 0.001 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 0.280 | 0.089-0.887 | 0.030 | 0.249 | 0.076-0.811 | 0.021 |
| Neonatal respiratory distress syndrome | ||||||
| Per 1 pg/mL | 1.002 | 0.965-1.039 | 0.931 | 1.007 | 0.968-1.048 | 0.712 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 0.737 | 0.161-3.367 | 0.694 | 0.811 | 0.165-3.997 | 0.797 |
| Composite adverse pregnancy outcomes | ||||||
| Per 1 pg/mL | 0.974 | 0.958-0.991 | 0.004 | 0.974 | 0.965-0.991 | 0.004 |
| PDX1<131pg/mL | Reference | Reference | ||||
| PDX1≥131pg/mL | 0.487 | 0.258-0.920 | 0.027 | 0.496 | 0.256-0.960 | 0.037 |
Model 1: not adjusted; Model 2: adjusted for age, preconception BMI, family history of diabetes, smoking exposure, alcohol consumption, and GDM.